Literature DB >> 9191733

Sarin poisoning on Tokyo subway.

S Ohbu1, A Yamashina, N Takasu, T Yamaguchi, T Murai, K Nakano, Y Matsui, R Mikami, K Sakurai, S Hinohara.   

Abstract

On the day of the disaster, 641 victims were seen at St. Luke's International Hospital. Among those, five victims arrived with cardiopulmonary or respiratory arrest with marked miosis and extremely low serum cholinesterase values; two died and three recovered completely. In addition to these five critical patients, 106 patients, including four pregnant women, were hospitalized with symptoms of mild to moderate exposure. Other victims had only mild symptoms and were released after 6 hours of observation. Major signs and symptoms in victims were miosis, headache, dyspnea, nausea, ocular pain, blurred vision, vomiting, coughing, muscle weakness, and agitation. Almost all patients showed miosis and related symptoms such as headache, blurred vision, or visual darkness. Although these physical signs and symptoms disappeared within a few weeks, psychologic problems associated with posttraumatic stress disorder persisted longer. Also, secondary contamination of the house staff occurred, with some sort of physical abnormality in more than 20%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191733     DOI: 10.1097/00007611-199706000-00002

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  22 in total

1.  Fear of terrorism in New York after the September 11 terrorist attacks: implications for emergency mental health and preparedness.

Authors:  Joseph A Boscarino; Charles R Figley; Richard E Adams
Journal:  Int J Emerg Ment Health       Date:  2003

Review 2.  Emotional and behavioral consequences of bioterrorism: planning a public health response.

Authors:  Bradley D Stein; Terri L Tanielian; David P Eisenman; Donna J Keyser; M Audrey Burnam; Harold A Pincus
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 3.  Toxicological assessments of Gulf War veterans.

Authors:  Mark Brown
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

4.  Fear of terrorism and preparedness in New York City 2 years after the attacks: implications for disaster planning and research.

Authors:  Joseph A Boscarino; Richard E Adams; Charles R Figley; Sandro Galea; Edna B Foa
Journal:  J Public Health Manag Pract       Date:  2006 Nov-Dec

5.  Assessing Community Reactions to Ebola Virus Disease and Other Disasters: Using Social Psychological Research to Enhance Public Health and Disaster Communications.

Authors:  Joseph A Boscarino; Richard E Adams
Journal:  Int J Emerg Ment Health       Date:  2015

Review 6.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

7.  Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.

Authors:  Tetsade C B Piermartiri; Hongna Pan; Jun Chen; John McDonough; Neil Grunberg; James P Apland; Ann M Marini
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

8.  Characterizing Chemical Terrorism Incidents Collected by the Global Terrorism Database, 1970-2015.

Authors:  Cynthia Santos; Tharwat El Zahran; Jessica Weiland; Mehruba Anwar; Joshua Schier
Journal:  Prehosp Disaster Med       Date:  2019-07-08       Impact factor: 2.040

9.  Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.

Authors:  Cynthia Gilley; Mary MacDonald; Florian Nachon; Lawrence M Schopfer; Jun Zhang; John R Cashman; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

10.  Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.

Authors:  A Gore; E Bloch-Shilderman; I Egoz; J Turetz; R Brandeis
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.